Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordic Nanovector ASA: Extraordinary general meeting held

Oslo, Norway, 14 February 2022 Nordic Nanovector ASA (the "Company") announces that an extraordinary general meeting (“EGM”) in the Company was held today at the Company's offices in Kjelsåsveien 168B, 0884 Oslo. The EGM approved all items on the agenda, including the authorisation to the board of directors (“Board”) to increase the share capital in connection with a potential repair offering as announced on 19 and 24 January 2022. The minutes from the EGM are attached and are also available at www.nordicnanovector.com. As previously announced, a repair offering is subject to (i) the

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 40 - 14 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 39 - 14 FEBRUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

Mikael Bäckström appointed as Chief People and Sustainability Officer for Tobii Dynavox

Tobii Dynavox, the world leader in assistive technology for communication, today announced that it has appointed Mikael Bäckström as Chief People and Sustainability Officer. He assumes the role with immediate effect as a key member in the Tobii Dynavox Management Team.    Mikael Bäckström is a proven leader within People and HR, with a track-record of building global HR organizations through periods of growth and with focus on building a sustainable business through culture and leadership. Most recently Bäckström was Vice President, HR at Spotify for seven years, where he was part of

Invitation to Q4 2021 webcast

Zalaris ASA will release its fourth quarter 2021 results on Friday 18 February 2022.Zalaris will host a webcast for all shareholders and interested parties on 18 February at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com. Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release February 14, 2022 at 10:55 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on February 11, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on February 10, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+-----

New Chief Commercial Officer to Payer as growth explodes

Payer, the leading B2B payments provider for digital commerce has appointed Stefan Backlund as new Chief Commercial Officer. Stefan is a payments veteran with leading marketing roles at Klarna and Trustly under his belt. He is now transitioning from the CMO role that he has had since 2019, at the time when the company started to receive its first transactions through its payments platform.Payer’s market position is within the enterprise B2B segment of industries such as manufacturing, banking & financial services and digital commerce. The company saw a 450% volume growth year-over-year 2021

Caverion Corporation considers issuance of new notes and announces a voluntary tender offer for its outstanding notes maturing in 2023

Caverion Corporation Inside information 14 February 2022 at 10.40 a.m. EETCaverion Corporation considers issuance of new notes and announces a voluntary tender offer for its outstanding notes maturing in 2023 Caverion Corporation (“Caverion”) is considering the issuance of new senior unsecured euro-denominated fixed rate notes (the “New Notes”). The potential issue is expected to be launched in the near future subject to market conditions. At the same time, Nordea Bank Abp (the “Offeror”) announces that it invites the holders (the “Holders”) of the EUR 75,000,000 3.250 per cent Notes due

Hilti Group achieves double-digit sales growth

The Hilti Group achieved total sales of nearly CHF 6 billion in 2021, 12.1 percent above the previous year’s level. In local currencies the increase in sales amounted to 12.2 percent.“The recovery trend in the construction industry continued during the last four months of 2021. We were able to maintain double-digit growth in a relatively stable currency environment and fully compensate for the coronavirus-related decline in sales of the previous year. This has allowed us to close the year well above the pre-crisis level in local currencies," explains CEO Christoph Loos. In Europe, sales

Agreements signed on electrical, automation and ICT for the Kemi bioproduct mill

Metsä Fibre press release 14.2.2022All the electrical, automation and ICT installation contracts for the Kemi bioproduct mill project of Metsä Fibre, part of Metsä Group, have now been agreed. The contracts form an important part of the whole bioproduct mill. Signed as planned and on schedule, the contracts includes all the mill’s process electricity, building electricity and instrument installations, as well as ICT cabling and equipment. The installations will begin in the spring of 2022 and end in the summer of 2023. Metsä Fibre’s partners in electrical, automation and ICT works are

Invitation to presentation of Isofol's year-end report 2021 on February 24, 2022

GOTHENBURG, Sweden, February 14, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s year-end report 2021 on Thursday, February 24, 2022. On the same day, Isofol invites investors, analysts, and media to an audiocast with a subsequent question time.In conjunction with the publication of the year-end report 2021, Isofol invites investors, analysts, and media to an audiocast on February 24, at 11:00 a.m. CET. The presentation will be held by Isofol´s CEO Ulf Jungnelius and CFO Gustaf Albèrt, who will present and comment the report, followed by a Q&

Contract for CSV Normand Valiant

Solstad Offshore ASA is pleased to announce contract award for the CSV Normand Valiant with PETROBRAS. The charter is 2 years firm with possibility of 2 years extension. Commencement of the contract will take place in 2Q 2022. The contract has a gross value of approximately NOK 350 million, including additional services. Normand Valiant will provide accommodation services to support production activities in the Brazilian continental shelf. Skudeneshavn, February 14[th], 2022 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad

Optomed’s Financial Statements Bulletin 2021 will be published on 17 February 2022

Optomed Plc    Press Release    14 February 2022 at 10.00, Helsinki Optomed’s Financial Statements Bulletin 2021 will be published on 17 February 2022 Optomed will publish its Financial Statements Bulletin 2021 on 17 February 2022 approximately at 9.00 EET.  A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest. The participants are requested to register for the call in advance by email

Outokumpu increases the share of low-carbon energy with a new wind power agreement

Outokumpu OyjPress releaseFebruary 14, 2022 at 10.00 am EETOutokumpu increases the share of low-carbon energy with a new wind power agreement Outokumpu has signed a 10-year power supply agreement for renewable wind power with Swiss electricity producer Alpiq. The amount of contracted wind power energy corresponds to over 60% of Outokumpu’s electricity consumption at its production sites in Germany. According to the agreement, deliveries will begin in January 2023. Increasing the share of low-carbon electricity is one of the most important methods for Outokumpu to achieve its

Cutting down on gifts or going into debt for Valentine’s Day – Europeans' attitudes differ

Millennials are more likely to take on debt to buy presents to their partner than their Boomer parents, but how does it differ between countries? Ahead of Valentine’s Day, European credit management company Intrum asked more than 24,000 people across Europe about their finances and how it interacts with their love lives. While many cut back on costly romantic gestures to make ends meet, others are prepared to go into debt in order to secure affection.“In a few countries, as many as 1 in 4 say they would choose debt before coming home empty handed to their spouse. It’s unfortunate that

BioStock: SynAct Pharma well positioned for an eventful 2022

Biotech company SynAct Pharma finished 2021 with strong phase IIa results for AP1189 in Rheumatoid Arthritis, supporting further development within this large and commercially attractive indication. They are now preparing for a phase IIb study in RA which will incorporate the new AP1189 tablets and three month dosing. Furthermore, a listing on Nasdaq Stockholm Main Market is in the pipeline for the first half year. BioStock reached out to CEO Jeppe Øvlesen and CSO Thomas Jonassen to learn more about what is in the cards for 2022Read the full article at biostock.se: https://www.biostock.

Kemira Oyj: Announcement of manager’s transaction; President and CEO Jari Rosendal has purchased 4,349 Kemira shares

Kemira Oyj, Managers' transactions, February 14, 2022 at 9.50 am (EET)Kemira Oyj: Announcement of manager’s transaction; President and CEO Jari Rosendal has purchased 4,349 Kemira shares Kemira has received a notification from Jari Rosendal, President and CEO, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below.Person subject to the notification requirement:Name: Rosendal, JariPosition: Chief Executive OfficerIssuer: KEMIRA LEI: 74370031Y7RK5H88CQ48Notification type:

BioStock: Invent Medic signs deal with German incontinence products company

Since the launch of the Efemia menstrual cup last autumn, much of Invent Medic’s focus has been on this product. However, this does not mean that Efemia continence support has been forgotten, in fact, the company recently announced signing a distribution agreement with the German company developing incontinence products, Sayco Europe. BioStock contacted Invent Medic’s Business Development Manager Carina Lindquist to find out more about the new distributor.Read the full article at biostock.se:https://www.biostock.se/en/2022/02/invent-medic-signs-deal-with-german-incontinence-products-

Sustainability Pays: OmboriGrid and Etihad Airways partner to deploy smart recycling kiosks at Abu Dhabi Sustainability Week

OmboriGrid AB (publ) has partnered with Etihad Airways, the national airline of United Arab Emirates, to launch a new sustainability initiative using smart recycling kiosks.OmboriGrid worked with INCOM TOMRA and Microsoft to develop the smart recycling kiosks that function as reverse vending machines (RVMs) connected to Etihad Guest’s loyalty programme, rewarding users for recycling plastic drink bottles and aluminium cans with Etihad Guest Miles in real-time. The first Grid-enabled Etihad Guest smart recycling kiosk made its debut at the Abu Dhabi Sustainability week on January 17, 2022.

Inhalation Sciences upgrades Quality Management System to further strengthen company and prepare for increased market requirements

(Stockholm, 14 February 2022) Inhalation Sciences (ISAB) is updating its Quality Management System - strengthening its competitiveness and efficiency in preclinical settings but also preparing for future use in clinical environments. ISAB will implement EN ISO 13485 with full implementation to be completed by June 2022.ISO 13485 implementation is widely recognized as a prestigious and trusted stamp of quality throughout the MedTech industry. It is associated with improved efficiencies, speed and consistency of service and operations – and higher customer satisfaction. ISAB is now

Implantica presents the fourth quarter 2021 on February 18 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the fourth quarter 2021 at 15:00 CET on February 18. The interim report for the fourth quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: Conference call dial-in: · Sweden: +46 8 505 583 75 · United Kingdom: +44 3333 009270 · United States: +1-646-722-4957 Webcast: · https://tv.streamfabriken.com/implantica-q4-2021 Speakers: · CEO Peter Forsell · CFO Andreas Öhrnberg · VP Operations & IR Nicole Pehrsson For

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (BlackRock, Inc.)

Nordea Bank AbpStock exchange release – Major shareholder announcements14 February 2022 at 09.30 EET Nordea Bank Abp has on 11 February 2022 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has crossed the threshold of 5 per cent on 10 February 2022. The total number of shares and voting rights in Nordea Bank Abp is 3,930,834,811. Total positions of BlackRock, Inc. and its funds according to the notification: +----------------+-------------

Bonava acquires a total of 550 building rights in Leipzig and Berlin

Bonava has signed an agreement with Reinbau GmbH and Baywobau Baubetreuung GmbH to acquire 300 building rights in Leipzig in the German federal state of Saxony. Bonava also signed an agreement with Pöttinger Wildau GmbH & Co. Dev. I KG to acquire 250 building rights in Wildau, just south of Berlin. The investments in land relate to consumer and rental housing projects and amount to approximately EUR 32.5 million. In Leipzig, the transaction is part of a collaboration with Reinbau GmbH concerning the development of projects in Portitz and may also enable future investments in the Leipzig

Cline Scientific welcomes Professor Emeritus Lars Peterson as new advisor

Cline Scientific announces the appointment of Professor Emeritus and Orthopedic Surgeon Lars Peterson as a new advisor for StemCART, Cline’s cell-based cartilage repair product.Lars Peterson has been a hugely influential figure in Orthopedics and Sports Medicine in Sweden and worldwide. Peterson was a pioneer of the autologous chondrocyte transplantation procedure for the repair of articular cartilage. Throughout his long career, Peterson has been a world-renowned orthopedic surgeon, was appointed Professor of Orthopaedic Surgery at the University of Gothenburg, and served as head physician

There are no items matching the current filter
There are no more items matching the current filter
Back to top